Skip to main content

Closing Bell: Medexus Pharmaceuticals Inc down on Wednesday (MDP)

Automated Summaries - The Globe and Mail - Wed Jul 17, 4:01PM CDT

In trading today, shares of Medexus Pharmaceuticals Inc opened at $2.30 and closed at $2.28. It traded at a low of $2.26 to a high of $2.33.

The price eased -0.87% from the previous day's close of $2.30.

Today across North America, the TSX Composite closed 1.07% at 22995.39, the S&P 500 closed 0.64% at 5667.20, the Dow Jones Industrial Average closed 1.85% at 40954.48 and the Nasdaq Composite closed 0.20% at 18509.34.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

Trading volume was 15,485 on 27 total trades, with an average volume of 19,860 over 5 days.

The TSX market on the whole today saw 2,100 price advancers against 3,108 declines and 117 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have boosted 11.76 percent in the last year, while in 2024, they have dipped -7.69%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $56.25 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Based on 4.00 analysts, Medexus Pharmaceuticals Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..